Cargando…

Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives

[Image: see text] 2-Aminobenzochromenes and dihydropyranochromenes represent a unique class of biologically active compounds. Recent organic syntheses focus on the development of environmentally benign synthetic protocols, and as a part of this concept, we have taken a considerable interest in the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholayil Palapetta, Surya, Gurusamy, Harichandran, Ganapasam, Sudhandiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979373/
https://www.ncbi.nlm.nih.gov/pubmed/36873031
http://dx.doi.org/10.1021/acsomega.2c06049
_version_ 1784899716010475520
author Cholayil Palapetta, Surya
Gurusamy, Harichandran
Ganapasam, Sudhandiran
author_facet Cholayil Palapetta, Surya
Gurusamy, Harichandran
Ganapasam, Sudhandiran
author_sort Cholayil Palapetta, Surya
collection PubMed
description [Image: see text] 2-Aminobenzochromenes and dihydropyranochromenes represent a unique class of biologically active compounds. Recent organic syntheses focus on the development of environmentally benign synthetic protocols, and as a part of this concept, we have taken a considerable interest in the synthesis of this class of biologically active compounds using an environment-friendly, reusable heterogeneous Amberlite IRA 400-Cl resin catalyst. This work further aims to highlight the importance and advantages of these compounds and to compare the experimental data obtained with those of the theoretical calculations made using the density functional theory (DFT) method. Molecular docking studies on the selected compounds were also carried out to study the effectiveness of these compounds in liver fibrosis treatment. Furthermore, we have performed molecular docking studies and an in vitro study of the anticancer activity of dihydropyrano[3,2-c]chromenes and 2-aminobenzochromenes against human colon cancer cells [HT29].
format Online
Article
Text
id pubmed-9979373
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99793732023-03-03 Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives Cholayil Palapetta, Surya Gurusamy, Harichandran Ganapasam, Sudhandiran ACS Omega [Image: see text] 2-Aminobenzochromenes and dihydropyranochromenes represent a unique class of biologically active compounds. Recent organic syntheses focus on the development of environmentally benign synthetic protocols, and as a part of this concept, we have taken a considerable interest in the synthesis of this class of biologically active compounds using an environment-friendly, reusable heterogeneous Amberlite IRA 400-Cl resin catalyst. This work further aims to highlight the importance and advantages of these compounds and to compare the experimental data obtained with those of the theoretical calculations made using the density functional theory (DFT) method. Molecular docking studies on the selected compounds were also carried out to study the effectiveness of these compounds in liver fibrosis treatment. Furthermore, we have performed molecular docking studies and an in vitro study of the anticancer activity of dihydropyrano[3,2-c]chromenes and 2-aminobenzochromenes against human colon cancer cells [HT29]. American Chemical Society 2023-02-17 /pmc/articles/PMC9979373/ /pubmed/36873031 http://dx.doi.org/10.1021/acsomega.2c06049 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Cholayil Palapetta, Surya
Gurusamy, Harichandran
Ganapasam, Sudhandiran
Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
title Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
title_full Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
title_fullStr Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
title_full_unstemmed Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
title_short Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
title_sort synthesis, characterization, computational studies, molecular docking, and in vitro anticancer activity of dihydropyrano[3,2-c]chromene and 2-aminobenzochromene derivatives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979373/
https://www.ncbi.nlm.nih.gov/pubmed/36873031
http://dx.doi.org/10.1021/acsomega.2c06049
work_keys_str_mv AT cholayilpalapettasurya synthesischaracterizationcomputationalstudiesmoleculardockingandinvitroanticanceractivityofdihydropyrano32cchromeneand2aminobenzochromenederivatives
AT gurusamyharichandran synthesischaracterizationcomputationalstudiesmoleculardockingandinvitroanticanceractivityofdihydropyrano32cchromeneand2aminobenzochromenederivatives
AT ganapasamsudhandiran synthesischaracterizationcomputationalstudiesmoleculardockingandinvitroanticanceractivityofdihydropyrano32cchromeneand2aminobenzochromenederivatives